ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
John M. Toomasian
Jonathan W. Haft
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sato, H.
Right arrow Articles by Cook, K. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sato, H.
Right arrow Articles by Cook, K. E.
Related Collections
Right arrow Lung - other

Ann Thorac Surg 2007;84:1136-1143
© 2007 The Society of Thoracic Surgeons

Original Articles: General Thoracic

Thirty-Day In-Parallel Artificial Lung Testing in Sheep

Hitoshi Sato, MD, Candice M. Hall, BS, LVT, Nathan G. Lafayette, BS, Joshua R. Pohlmann, BS, Niru Padiyar, MD, John M. Toomasian, MS, Jonathan W. Haft, MD, Keith E. Cook, PhD*

Department of Surgery, University of Michigan, Ann Arbor, Michigan

Accepted for publication May 18, 2007.

* Address correspondence to Dr Cook, 7679 Kresge I, 200 Zina Pitcher Pl, Ann Arbor, MI 48109 (Email: keicook{at}umich.edu).

Presented at the Forty-third Annual Meeting of The Society of Thoracic Surgeons, San Diego, CA, Jan 29–31, 2007.

Background: Thirty-day testing of the MC3 Biolung (MC3 Inc, Ann Arbor, MI) total artificial lung (TAL) was performed to prepare for future clinical testing.

Methods: TAL inlet and outlet grafts were sewn to the pulmonary artery and left atrium of 8 sheep (35.6 ± 1.6 kg), and the TAL was attached the next day. Hemodynamic and sheep blood gas data were measured every 1 to 4 hours. TAL blood gases were measured twice daily, and organ function was assessed three times per week. The TAL was replaced if its resistance increased 300% or if the oxygen content difference across the TAL decreased 25% versus baseline. After 30 days, the sheep were euthanized and necropsied.

Results: Five sheep survived 30 days. Three sheep were euthanized before 30 days due to bleeding, mechanical graft failure, or gastric distress. Survivors had normal, stable hemodynamics and blood gases. Average device use was 9.5 ± 2.1 days. TAL oxygen transfer was 108 ± 9.2 mL/min with 51% ± 6.3% of cardiac output flowing to the TAL. TAL resistance and flow were 1.3 ± 0.3 mm Hg · min/L and 2.4 ± 0.2 L/min at baseline versus 2.6 ± 0.9 mm Hg · min/L and 2.0 ± 0.2 L/min for the remaining 30 days. Platelet and white blood cell counts increased 88% and 84% from baseline, respectively, after 10 days and were stable thereafter. Ischemic lesions in the kidney were seen in most sheep at necropsy, but organ function was normal.

Conclusions: Thirty-day respiratory support was feasible with the Biolung, but improvements in biocompatibility and anticoagulation regimen are warranted to reduce the thrombogenicity of the device.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 by The Society of Thoracic Surgeons.